I-131-Tositumomab (Bexxar®)
131I-Tositumomab is a radiolabeled anti-CD20 antibody launched in 2003 under [...]
131I-Tositumomab is a radiolabeled anti-CD20 antibody launched in 2003 under [...]
188Re-ImDendrim is an in-situ delivery system made from dendrimer diffusible [...]
177Lu-FAPI-04 is the therapeutic analogue of the PET imaging agent [...]
177Lu-iPSMA is the therapeutic analogue of 99mTc-iPSMA developed at [...]
177Lu-FAP-2286 (177Lu-3BP-2286) is a molecule from the FAPi family [...]
90Y-DOTA-FF-21101 is a chimeric monoclonal anti-P-Cadherin (CDH3) labeled with Yttrium-90 [...]
OncoSil™ (originally called BrachySil™) is a 32P-loaded microparticle developed [...]
90Y-IsoPet is a hydrogel liquid made of water-based biodegradable polymer [...]
90Y-microspheres are resin- (SIRSpheres) or glass- (TheraSpheres) based microspheres [...]
131I-Lipiodol (131I-Ethiodized Oil) is a generic therapeutic agent which was [...]